166 related articles for article (PubMed ID: 36289489)
1. Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis.
Li Y; Yu H; Lv M; Li Q; Zou K; Lv S
BMC Pulm Med; 2022 Oct; 22(1):388. PubMed ID: 36289489
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with budesonide and acetylcysteine alleviates LPS-induced acute lung injury via the miR-381/NLRP3 molecular axis.
Yu H; Lv M; Zhang S; Zou K; Qian Y; Lv S
PLoS One; 2023; 18(8):e0289818. PubMed ID: 37556466
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 alleviates sepsis-induced acute lung injury by regulating the miR-107/TGFBR3 axis.
Hao X; Wei H
BMC Pulm Med; 2022 Sep; 22(1):371. PubMed ID: 36180862
[TBL] [Abstract][Full Text] [Related]
4. The Functional Mechanisms of miR-30b-5p in Acute Lung Injury in Children.
Zhou T; Chen YL
Med Sci Monit; 2019 Jan; 25():40-51. PubMed ID: 30600796
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-196b-5p attenuates BCG uptake via targeting SOCS3 and activating STAT3 in macrophages from patients with long-term cigarette smoking-related active pulmonary tuberculosis.
Yuan Y; Lin D; Feng L; Huang M; Yan H; Li Y; Chen Y; Lin B; Ma Y; Ye Z; Mei Y; Yu X; Zhou K; Zhang Q; Chen T; Zeng J
J Transl Med; 2018 Oct; 16(1):284. PubMed ID: 30326918
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of N-acetylcysteine and dexmedetomidine plays a synergistic effect on protection of LPS-induced acute lung injury via correcting Th1/Th2/Th17 cytokines imbalance.
Song Q; Lin L; Chen L; Cheng L; Zhong W
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):294-301. PubMed ID: 31631367
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
8. Xuebijing improves inflammation and pyroptosis of acute lung injury by up-regulating miR-181d-5p-mediated SPP1 inactivation.
Wu X; Xin R; Zhang Y; Yang C; Sun F; Wang Y; Zheng F
Clinics (Sao Paulo); 2024; 79():100336. PubMed ID: 38325020
[TBL] [Abstract][Full Text] [Related]
9. An anticomplement homogeneous polysaccharide from Hedyotis diffusa attenuates lipopolysaccharide-induced acute lung injury and inhibits neutrophil extracellular trap formation.
Zhang J; Huo J; Zhao Z; Lu Y; Hong Z; Li H; Chen D
Phytomedicine; 2022 Dec; 107():154453. PubMed ID: 36116199
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury.
Dai L; Zhang G; Cheng Z; Wang X; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Connect Tissue Res; 2018 Nov; 59(6):581-592. PubMed ID: 29649906
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents.
Mitsopoulos P; Omri A; Alipour M; Vermeulen N; Smith MG; Suntres ZE
Int J Pharm; 2008 Nov; 363(1-2):106-11. PubMed ID: 18694812
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA OIP5-AS1 aggravates acute lung injury by promoting inflammation and cell apoptosis via regulating the miR-26a-5p/TLR4 axis.
Sun Q; Luo M; Gao Z; Han X; Wu W; Zhao H
BMC Pulm Med; 2021 Jul; 21(1):236. PubMed ID: 34261477
[TBL] [Abstract][Full Text] [Related]
13. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
14. Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C(+) macrophages.
Jiang Z; Chen Z; Li L; Zhou W; Zhu L
Respir Res; 2017 Dec; 18(1):217. PubMed ID: 29284516
[TBL] [Abstract][Full Text] [Related]
15. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of circRNA Paralemmin 2 Ameliorates Lipopolysaccharide-induced Murine Lung Epithelial Cell Injury by Sponging miR-330-5p to Reduce ROCK2 Expression.
Ren Y; Li L; Wang M; Yang Z; Sun Z; Zhang W; Cao L; Nie S
Immunol Invest; 2022 Aug; 51(6):1707-1724. PubMed ID: 35171050
[TBL] [Abstract][Full Text] [Related]
17. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.
Jansson AH; Eriksson C; Wang X
Vascul Pharmacol; 2005 Aug; 43(2):101-11. PubMed ID: 15967733
[TBL] [Abstract][Full Text] [Related]
18. BMSC-Derived Exosomes Ameliorate LPS-Induced Acute Lung Injury by miR-384-5p-Controlled Alveolar Macrophage Autophagy.
Liu X; Gao C; Wang Y; Niu L; Jiang S; Pan S
Oxid Med Cell Longev; 2021; 2021():9973457. PubMed ID: 34234888
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol decreases CD45
Hu L; Chen Z; Li L; Jiang Z; Zhu L
J Cell Mol Med; 2019 Dec; 23(12):8101-8113. PubMed ID: 31559687
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-145-5p alleviated LPS-induced acute lung injury.
Yu YL; Yu G; Ding ZY; Li SJ; Fang QZ
J Biol Regul Homeost Agents; 2019; 33(4):1063-1072. PubMed ID: 31353880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
